MedTrace Logo

Impact of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 4-6 Years Old

NCT07479394 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-07-10

No results posted yet for this study

Summary

This is a study to evaluate the effects of a prebiotic, AHCC, a standardized extract of cultured Lentinula edodes mycelia, on immunologic markers and the incidence of respiratory tract infections in children.

Conditions

  • Respiratory Tract Infections (RTI)

Interventions

DIETARY_SUPPLEMENT

a prebiotic, that us a standardized extract of cultured Lentinula edodes mycelia

Subjects will be administered dextrin including AHCC.

DIETARY_SUPPLEMENT

Placebo (dextrin)

Subjects will be administered dextrin alone (placebo)

Sponsors & Collaborators

  • Amino Up Co. Ltd., Sapporo, Japan

    collaborator UNKNOWN

  • Hasanuddin University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-15
Primary Completion
2027-02-28
Completion
2027-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07479394 on ClinicalTrials.gov